Back Login for AI Analysis

    TSHA (STOCKS)

    Taysha Gene Therapies, Inc. Common Stock

    $4.625000
    +0.205000 (+4.64%)
    Prev close: $4.420000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Sean P. Nolan
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $1,328.62M
    Employees
    73
    P/E (TTM)
    -12.26
    P/B (TTM)
    5.10
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Analyst Recommendations
    6
    Strong Buy
    13
    Buy
    1
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Dec 2025 (Q4)
    		 $-0.08 $-0.10 +0.0181 +18.45%
    Sep 2025 (Q3)
    		 $-0.09 $-0.09 +0.0000 +0.00%
    Jun 2025 (Q2)
    		 $-0.09 $-0.08 -0.0075 -9.09%
    Mar 2025 (Q1)
    		 $-0.08 $-0.09 +0.0144 +15.25%
    Financial Statements
    TTM (Dec 2025)
    Revenues $9.77M
    Benefits Costs and Expenses $118.77M
    Costs And Expenses $118.77M
    Nonoperating Income/Loss $1.50M
    Operating Expenses $120.27M
    Research and Development $86.40M
    Other Operating Expenses $33.87M
    Operating Income/Loss -$110.50M
    Income/Loss From Continuing Operations After Tax -$109.00M
    Income/Loss From Continuing Operations Before Tax -$109.00M
    Income Tax Expense/Benefit $0.00
    Net Income/Loss -$109.00M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$109.00M
    Net Income/Loss Available To Common Stockholders, Basic -$109.00M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$0.34
    Diluted Earnings Per Share -$0.34
    Basic Average Shares 319,711,972
    Diluted Average Shares 319,711,972
    Assets $343.32M
    Current Assets $324.65M
    Noncurrent Assets $18.67M
    Fixed Assets $6.74M
    Other Non-current Assets $11.94M
    Liabilities $96.38M
    Current Liabilities $26.55M
    Accounts Payable $6.28M
    Wages $9.43M
    Other Current Liabilities $10.85M
    Noncurrent Liabilities $69.83M
    Equity $246.94M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $246.94M
    Liabilities And Equity $343.32M
    Net Cash Flow From Operating Activities -$93.09M
    Net Cash Flow From Operating Activities, Continuing -$93.09M
    Net Cash Flow From Investing Activities -$604.00K
    Net Cash Flow From Investing Activities, Continuing -$604.00K
    Net Cash Flow From Financing Activities $274.59M
    Net Cash Flow From Financing Activities, Continuing $274.59M
    Net Cash Flow $180.90M
    Net Cash Flow, Continuing $180.90M
    Comprehensive Income/Loss -$105.16M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$105.16M
    Other Comprehensive Income/Loss $3.84M
    Related Companies
    HHH